This invention relates to a series of PTH and PTHrP analogues that selectively bind to PTH2 receptors and as such may be useful in treating abnormal CNS functions; abnormal pancreatic functions; divergence from normal mineral metabolism and homeostasis; male infertility; regulation of abnormal blood pressure; and hypothalmic disease.

 
Web www.patentalert.com

< Modified Fc molecules

> Cytokine zalpha11 ligand polynucleotides

> 2-methylene-1.alpha.-hydroxy-19,21-dinorvitamin D.sub.3 analogs and uses thereof

~ 00518